Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Nov;41(11):e1900086.
doi: 10.1002/bies.201900086. Epub 2019 Oct 7.

Granulomatous Inflammation in Tuberculosis and Sarcoidosis: Does the Lymphatic System Contribute to Disease?

Affiliations
Review

Granulomatous Inflammation in Tuberculosis and Sarcoidosis: Does the Lymphatic System Contribute to Disease?

Karen C Patterson et al. Bioessays. 2019 Nov.

Abstract

A striking and unexplained feature of granulomatous inflammation is its anatomical association with the lymphatic system. Accumulating evidence suggests that lymphatic tracks and granulomas may alter the function of each other. The formation of new lymphatics, or lymphangiogenesis, is an adaptive response to tumor formation, infection, and wound healing. Granulomas also may induce lymphangiogenesis which, through a variety of mechanisms, could contribute to disease outcomes in tuberculosis and sarcoidosis. On the other hand, alterations in lymph node function and lymphatic draining may be primary events which attenuate the risk and severity of granulomatous inflammation. This review begins with an introduction of granulomatous inflammation and the lymphatic system. A role of the lymphatic system in tuberculosis and sarcoidosis is then hypothesized. With a focus on lymphangiogenesis in these diseases, and on the potential for this process to promote dissemination, parallels are established with the well-established role of lymphangiogenesis in tumor biology.

Keywords: granulomas; lymphatics; sarcoidosis; tuberculosis.

PubMed Disclaimer

Comment in

References

    1. A. J. Pagan, L. Ramakrishnan, Annu. Rev. Immunol. 2018, 36, 639.
    1. T. W. Foreman, S. Mehra, D. N. LoBato, A. Malek, X. Alvarez, N. A. Golden, A. N. Bucsan, P. J. Didier, L. A. Doyle-Meyers, K. E. Russell-Lodrigue, C. J. Roy, J. Blanchard, M. J. Kuroda, A. A. Lackner, J. Chan, S. A. Khader, W. R. Jacobs Jr., D. Kaushal, Proc. Natl. Acad. Sci. USA 2016, 113, E5636.
    1. D. M. Scollard, L. B. Adams, T. P. Gillis, J. L. Krahenbuhl, R. W. Truman, D. L. Williams, Clin. Microbiol. Rev. 2006, 19, 338.
    1. World Health Organization, World Report on Disability, Geneva, Switzerland, 2011.
    1. M. S. Miranda, A. Breiman, S. Allain, F. Deknuydt, F. Altare, Clin. Dev. Immunol. 2012, 2012, 139127.

Publication types

LinkOut - more resources